Arsenic: Clinical Trials

6 trials of Arsenic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 recruiting, 1 withdrawn. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 2, Completed 1, Recruiting 1
Phase 11Completed 1
Phase 31Withdrawn 1

Follow Arsenic: new trials by email Literature Review of Arsenic trials Research Report on Arsenic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral Arsenic With ATRA for Newly Diagnosed Patients With Acute Promyelocytic Leukemia
Realgar-Indigo Naturalis Formulation - Acute Promyelocytic Leukemia (APL)
Phase 2RecruitingInstituto do Cancer do Estado de São Paulo1152023-10-202025-05-30
Arsenic Trioxide for Structural p53 Mutations
Arsenic Trioxide - Arsenic Trioxide, p53 Mutations
Phase 2UnknownShanghai Changzheng Hospital302021-01-012021-01-06
Feasibility of Implementing RINEW Through the Government System
Integrated child stimulation, nutrition, lead, arsenic, WASH intervention - Early Childhood Development
CompletedStanford University28232019-04-062022-05-17
Decitabine and Arsenic Trioxide for Myelodysplastic Syndrome(MDS)
Decitabine, Arsenic Trioxide - Myelodysplastic Syndromes, P53 Mutation
Phase 3WithdrawnLi Junmin2018-03-202023-08-16
Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 Mutations
Decitabine, Arsenic Trioxide, Cytarabine - Acute Myeloid Leukemia, P53 Mutation
Phase 2UnknownLi Junmin1002018-03-012018-01-04
Studies of Immune Responses to Orally Administered Vaccines in Developing Country
Placebo, Control, Zinc Sulphate - Cholera, Typhoid
Phase 1 / Phase 2CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh10162008-02-012011-07-12

Conditions studied

Cholera (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Promyelocytic, Acute (1)  ·  Myelodysplastic Syndromes (1)  ·  Neoplasms (1)  ·  Typhoid Fever (1)

Sponsors

Li Junmin (2)  ·  Instituto do Cancer do Estado de São Paulo (1)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (1)  ·  Shanghai Changzheng Hospital (1)  ·  Stanford University (1)

Countries

China (3)  ·  Bangladesh (2)  ·  Brazil (1)

Top investigators

Lu Min (2)  ·  Zhang Sujiang (2)  ·  Eduardo M Rego, MD PhD (1)  ·  Firdausi Qadri, PhD (1)  ·  Stephen P Luby, Dr. (1)

Results publications

PMID 35417717, PMID 37312017, PMID 40685160